Well as a previous holder you should know this was always about Europe once ResAppDx got CE Mark, MSF were only doing field studies and didn't continue (hence why ResAppDx is now being evaluated in clinic in Africa after receiving regulatory approval), the project with Lockheed Martin was completed, we all know why the FDA decline the submission after taking
10 months to review the submission.......
- Forums
- ASX - By Stock
- Ann: Clinical study to develop COVID-19 screening test
Well as a previous holder you should know this was always about...
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable